These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 14585649)

  • 21. Beta blockers or angiotensin-converting-enzyme inhibitor/angiotensin receptor blocker: what should be first?
    Remme WJ
    Cardiol Clin; 2007 Nov; 25(4):581-94; vii. PubMed ID: 18063162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
    Khattar RS; Senior R; Soman P; van der Does R; Lahiri A
    Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COMET: a proposed mechanism of action to explain the results and concerns about dose.
    Hjalmarson A; Waagstein F
    Lancet; 2003 Sep; 362(9389):1077; author reply 1077-8. PubMed ID: 14522544
    [No Abstract]   [Full Text] [Related]  

  • 24. Beta blockers in heart failure.
    Dargie HJ
    Lancet; 2003 Jul; 362(9377):2-3. PubMed ID: 12853188
    [No Abstract]   [Full Text] [Related]  

  • 25. Could beta-blockers precede or replace angiotensin-converting enzyme inhibitors in heart failure?
    Remme WJ
    Heart Fail Clin; 2005 Apr; 1(1):67-75. PubMed ID: 17386835
    [No Abstract]   [Full Text] [Related]  

  • 26. The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN).
    Remme WJ; Riegger G; Hildebrandt P; Komajda M; Jaarsma W; Bobbio M; Soler-Soler J; Scherhag A; Lutiger B; Rydén L
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):57-66. PubMed ID: 15115904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early recovery of impaired coronary flow reserve by carvedilol therapy in patients with idiopathic dilated cardiomyopathy: a serial transthoracic Doppler echocardiographic study.
    Sugioka K; Hozumi T; Takemoto Y; Ujino K; Matsumura Y; Watanabe H; Fujimoto K; Yoshiyama M; Yoshikawa J
    J Am Coll Cardiol; 2005 Jan; 45(2):318-9. PubMed ID: 15653035
    [No Abstract]   [Full Text] [Related]  

  • 28. Which beta-blocker is most effective in heart failure?
    Remme WJ
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):351-8. PubMed ID: 20596764
    [No Abstract]   [Full Text] [Related]  

  • 29. Carvedilol: use in chronic heart failure.
    Doughty RN; White HD
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late gadolinium enhancement on cardiac magnetic resonance images predicts reverse remodeling in patients with nonischemic cardiomyopathy treated with carvedilol.
    Kida K; Yoneyama K; Kobayashi Y; Takano M; Akashi YJ; Miyake F
    Int J Cardiol; 2013 Sep; 168(2):1588-9. PubMed ID: 23416019
    [No Abstract]   [Full Text] [Related]  

  • 31. Should we be screening for myocardial hibernation in heart failure?
    Lim ET; Lahiri A
    J Nucl Cardiol; 2004; 11(2):114-7. PubMed ID: 15052241
    [No Abstract]   [Full Text] [Related]  

  • 32. The impact of baseline left ventricular size and mitral regurgitation on reverse left ventricular remodelling in response to carvedilol: size doesn't matter.
    Kotlyar E; Hayward CS; Keogh AM; Feneley M; Macdonald PS
    Heart; 2004 Jul; 90(7):800-1. PubMed ID: 15201254
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of carvedilol in daily practice].
    Cohen-Solal A; Logeart D; Guiti C; Bourgoin P
    Ann Cardiol Angeiol (Paris); 1999 Nov; 48(9-10):647-51. PubMed ID: 12555472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Carvedilol in cardiac decompensation].
    Dib J
    Rev Med Liege; 1996 Feb; 51(2):198-200. PubMed ID: 8650455
    [No Abstract]   [Full Text] [Related]  

  • 35. Switching to once-daily evidence-based [beta]-blockers in patients with systolic heart failure or left ventricular dysfunction after myocardial infarction.
    Albert NM
    Crit Care Nurse; 2007 Dec; 27(6):62-72. PubMed ID: 18032686
    [No Abstract]   [Full Text] [Related]  

  • 36. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
    Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
    Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carvedilol saves lives--new data from landmark trials prove survival benefits in heart failure and post myocardial infarction.
    Cardiovasc J S Afr; 2001; 12(2):122-3. PubMed ID: 11474697
    [No Abstract]   [Full Text] [Related]  

  • 38. The MIBG tarot: is it possible to predict the efficacy of beta-blockers in congestive heart failure?
    Baliga RR; Narula J; Dec GW
    J Nucl Cardiol; 2001; 8(1):107-9. PubMed ID: 11303496
    [No Abstract]   [Full Text] [Related]  

  • 39. Autonomic dysfunction and beta blocker therapy in Chagas heart disease.
    Bestetti RB; Cardinalli-Neto A
    Clinics (Sao Paulo); 2013; 68(2):275-6. PubMed ID: 23525327
    [No Abstract]   [Full Text] [Related]  

  • 40. β-arrestin-biased signaling through the β2-adrenergic receptor promotes cardiomyocyte contraction.
    Carr R; Schilling J; Song J; Carter RL; Du Y; Yoo SM; Traynham CJ; Koch WJ; Cheung JY; Tilley DG; Benovic JL
    Proc Natl Acad Sci U S A; 2016 Jul; 113(28):E4107-16. PubMed ID: 27354517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.